account_id none on file
legal_name Indaptus Therapeutics, Inc.
ticker INDP
cik 1857044
domain indaptusrx.com
linkedin_company_url https://www.linkedin.com/company/indaptus-therapeutics-inc
entry_point_account_id none on file
name Indaptus Therapeutics Inc.
exchange Nasdaq
sector Health Care
sector index/company/sector/health-care/
calls 0 filings 3 executives 4 family 0
why_nownone on file
callsnone on file
filings
or meetings with management in accordance with a travel policy, as may be in effect from time to time. In March 2023, the Board amended our director compensation policy to provide that, on the date an individual is first elected or appointed as a non-employee director, such individual will receive a grant of 25,000 stock options, and that, on the date of each annual meeting of stockholders, commencing with the annu
filing / Jul 16, 2026 / receipt
Ding has served as our Chief Financial Officer since April 2026 and is a financial executive with over 20 years of extensive experience
filing / Jul 16, 2026 / receipt
delivery method is referred to as “householding” and can result in significant cost savings. To take advantage of this opportunity,
filing / Jul 16, 2026 / receipt
executives
| Junyi Dai | Chairman of the Board | - | receipt |
| Nir Sassi | Chief Financial Officer | receipt | |
| Walt A. Linscott | Chief Operating Officer | - | receipt |
| Yu Ding | Chief Financial Officer | - | receipt |
familynone on file
upcoming
| 2026-11-11 | earnings call | scheduled | ir |
changes
| 2026-04-03 | Chief Financial Officer, appointed | sec_8k |
| 2026-04-03 | Chief Financial Officer, departed | sec_8k |
| 2026-03-24 | Chairman of the Board, appointed | sec_8k |
| 2023-03-23 | Chief Operating Officer, appointed | sec_8k |
mcp_package_hint
slug indaptus-therapeutics-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$